Get started
Author

Godolfino Miranda-Zazueta

Observed names: G. Miranda-Zazueta, Godolfino M. Zazueta, Godolfino Miranda Zazueta, Godolfino Zazueta, Miranda Godolfino
OpenAlex ID: A5023980207
Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium
2023 · Jasmohan S Bajaj, Ashok K Choudhury, et al. · The Lancet. Gastroenterology & hepatology · 42
Low Thoracic Skeletal Muscle Area Is Not Associated With Negative Outcomes in Patients With COVID-19
2021 · Paulina Moctezuma-Velázquez, Godolfino Miranda-Zazueta, et al. · American Journal of Physical Medicine & Rehabilitation · 42
Effects of immunosuppressive drugs on COVID‐19 severity in patients with autoimmune hepatitis
2021 · Cumali Efe, Craig Lammert, et al. · Liver International · 41
PDF
Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission
2021 · Manuel Mendizabal, Federico Piñero, et al. · Annals of Hepatology · 35
PDF
Position statement on the use of albumin in liver cirrhosis
2022 · Graciela Castro-Narro, Carlos Moctezuma-Velázquez, et al. · Annals of Hepatology · 31
Bacterial infections in cirrhosis: Current treatment
2019 · Godolfino Miranda-Zazueta, Luis A. Ponce de León-Garduño, et al. · Annals of Hepatology · 27
PDF
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis
2022 · Cumali Efe, Koray Taşçılar, et al. · Journal of Autoimmunity · 19
Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection
2021 · Manuel Mendizabal, Ezequiel Ridruejo, et al. · Annals of Hepatology · 19
PDF
NAFLD determined by Dallas Steatosis Index is associated with poor outcomes in COVID-19 pneumonia: a cohort study
2022 · Paulina Moctezuma-Velázquez, Godolfino Miranda-Zazueta, et al. · Internal and Emergency Medicine · 16
The impact of different infectious complications on mortality of hospitalized patients with liver cirrhosis
2020 · Héctor Adrián Díaz-Hernández, Gerardo Vázquez-Anaya, et al. · Annals of Hepatology · 11
PDF
Consensus document on acute-on-chronic liver failure (ACLF) established by the Mexican Association of Hepatology
2023 · Aldo Torre, Laura Esthela Cisneros-Garza, et al. · Annals of Hepatology · 8
Pharmacologic management of patients with hepatic and pancreatic diseases that involve immunosuppressive therapies. Positioning within the framework of the SARS-CoV-2 (COVID-19) pandemic
2020 · G. Miranda-Zazueta, J.A. González-Regueiro, et al. · Revista de Gastroenterología de México (English Edition) · 3
PDF
Manejo farmacológico de pacientes con enfermedades hepáticas y pancreáticas que involucran terapias inmunosupresoras. Posicionamiento en el marco de la pandemia de SARS-CoV-2 (COVID-19)
2020 · G. Miranda-Zazueta, J.A. González-Regueiro, et al. · Revista de Gastroenterología de México · 2
PDF
Social determinants of health and access to liver transplantation in patients with hepatocellular carcinoma within a universal healthcare system: A retrospective cohort study
2026 · Carlos Moctezuma-Velazquez, Kinjal Patel, et al. · Liver Transplantation · 1
Abnormal liver function tests on admission are associated with increased mortality in hospitalized patients with Covid-19: preliminary results from a large latin american cohort
2020 · Manuel Mendizábal, Ezequiel Ridruejo, et al. · Universidad de Chile · 1
FRI-185 Outpatient sbp prophylaxis associates with higher sbp reccurence in a global cohort of cirrhosis inpatients with greatest impact in high-income countries
2025 · Jasmohan Bajaj, Qing Xie, et al. · Journal of Hepatology
FRI-053 Wide variations in proton pump inhibitor use in hospitalized patients with cirrhosis in a worldwide cohort shows little impact on clinically significant outcomes
2024 · Jasmohan Bajaj, Patrick S. Kamath, et al. · Journal of Hepatology
Nosocomial infections in cirrhosis are unpredictable and vary based on region of the world: CLEARED study
2023 · Jasmohan S Bajaj, Florence Wong, et al. · Journal of Hepatology
Characteristics of the endoscopic procedures performed in a hybrid tertiary-level hospital during the first year of the COVID-19 pandemic
2022 · Héctor Díaz Hernández, José Cuevas Castillejos, et al. · Gastroenterology Review
PDF
Risk factors for short-term post discharge clinical outcomes in patients hospitalized with decompensated chronic liver disease: interim results from Global CLEARED study
2022 · Jasmohan S. Bajaj, Patrick S. Kamath, et al. · Journal of Hepatology
CLEARED Global consortium results highlight regional variation and need for equity in inpatient outcomes in hospitalized patients with Chronic Liver Disease
2022 · Jasmohan S. Bajaj, Patrick S. Kamath, et al. · Journal of Hepatology
A Rare Case of Bowel Obstruction
2022 · L.E. Zamora Nava, G. Miranda-Zazueta · Endoscopy
P-13 Comparison Off Different Prognostic Scores for Patients With Cirrhosis Hospitalized With Sars – Cov 2 Infection
2021 · Manuel Mendizabal, Ezequiel Ridruejo, et al. · Annals of Hepatology
Pharmacologic management of patients with hepatic and pancreatic diseases that involve immunosuppressive therapies. Positioning within the framework of the SARS-CoV-2 (COVID-19) pandemic☆ Manejo farmacológico de pacientes con enfermedades hepáticas y pancreáticas que involucran terapias inmunosupresoras. Posicionamiento en el marco de la pandemia de SARS-CoV-2 (COVID-19)
2020 · Godolfino Miranda-Zazueta, José A González-Regueiro, et al. · Revista de Gastroenterología de México (English Edition)
Works count: 25
Citation count: 298
H-index: 10
I10-index: 10
Year
Topic
Type